Nuwellis, Inc. (NASDAQ:NUWE) Short Interest Down 21.3% in February

Nuwellis, Inc. (NASDAQ:NUWE) was the recipient of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 207,800 shares, a drop of 21.3% from the February 13th total of 264,200 shares. Based on an average daily trading volume, of 516,100 shares, the short-interest ratio is currently 0.4 days. Approximately 4.8% of the company’s shares are short sold.

Nuwellis Trading Up 1.3 %

Shares of NASDAQ NUWE traded up $0.01 on Wednesday, reaching $1.12. 9,320 shares of the company traded hands, compared to its average volume of 995,717. The stock has a market capitalization of $4.92 million, a PE ratio of -0.01 and a beta of 0.36. Nuwellis has a fifty-two week low of $0.92 and a fifty-two week high of $16.63. The company has a 50 day moving average of $1.21 and a 200 day moving average of $1.33.

Hedge Funds Weigh In On Nuwellis

A hedge fund recently bought a new stake in Nuwellis stock. Geode Capital Management LLC purchased a new position in shares of Nuwellis, Inc. (NASDAQ:NUWE) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned approximately 0.70% of Nuwellis as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 3.13% of the company’s stock.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.